Insider · SEC Form 4 filer
Patrick Enright
Past buys: 2 of 5 beat
Companies
Where they file as an insider
Veradermics (MANE) Director Latest filing Nov 11, 2026
Jazz Pharmaceuticals (JAZZ) Director Latest filing Aug 31, 2026
Vera Therapeutics (VERA) Director Latest filing Dec 11, 2025
Zenas BioPharma (ZBIO) Director Latest filing Oct 9, 2025
BioAge Labs (BIOA) Director Latest filing Sep 27, 2024
Track record
Did their buys beat the typical stock?
Open-market buys11
Quarters checked 6 months later5
Beat the typical stock 2 of 5
Quarters too new to check0
2 of 5 checked quarters beat the typical stock. A past record is data, not a forecast.
Veradermics (MANE) Bought Feb 5, 2026 · $18.3M · 1.07M shares Beat typical Mar 31, 2026 $63.15 → Sep 30, 2026 $121.23 · +92.0% (typical stock +1.7%)
Vera Therapeutics (VERA) Bought Dec 11, 2025 · $250K · 5,882 shares Behind typical Dec 31, 2025 $50.64 → Jun 30, 2026 $42.91 · −15.3% (typical stock +4.7%)
Zenas BioPharma (ZBIO) Bought Oct 9, 2025 · $2.25M · 117,255 shares Behind typical Dec 31, 2025 $36.31 → Jun 30, 2026 $25.38 · −30.1% (typical stock +4.7%)
Vera Therapeutics (VERA) Bought Jun 23–24, 2025 · $5.28M · 250,000 shares Beat typical Jun 30, 2025 $23.56 → Dec 31, 2025 $50.64 · +114.9% (typical stock +2.1%)
BioAge Labs (BIOA) Bought Sep 27, 2024 · $7.2M · 400,000 shares Not counted Not counted. We have no fund price for this stock on both Sep 30, 2024 and Mar 31, 2025.
Zenas BioPharma (ZBIO) Bought Sep 16, 2024 · $7.48M · 440,000 shares Behind typical Sep 30, 2024 $16.92 → Mar 31, 2025 $7.90 · −53.3% (typical stock −7.5%)
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.